The Tromsø Study: the positive predictive value of gamma-glutamyltransferase and an alcohol questionnaire in the detection of early-stage risk drinkers.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1675245.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Based on the measurement of gamma-glutamyltransferase and a questionnaire on frequency of alcohol intake, 338 early-stage risk drinkers were identified from more than 20,000 participants in a health survey programme. Two-thirds (225) of these subjects were questioned regarding their 'true' alcohol intake at the first consultation. Positive predictive values were calculated for true daily intake of 30 and 40 g alcohol d-1 for men (20 and 30 g alcohol d-1 for women) on the basis of gamma-glutamyltransferase activity and the response to a questionnaire. The positive predictive values for a risk intake of 30 g d-1 in men increased from 0.49 to 0.88, with increasing values for gamma-glutamyltransferase activity and increasing frequency of alcohol intake. The corresponding values for a risk intake of 40 g d-1 were 0.34-0.75. In women, increasing gamma-glutamyltransferase activity gave no increase in positive predictive values. The estimates for increasing frequency of alcohol intake were unreliable due to small numbers.
Medical subject headings
- Adolescent
- Adult
- Alcoholism
- Alcoholism/diagnosis
- Child
- Clinical Enzyme Tests
- Female
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Surveys and Questionnaires
- gamma-Glutamyltransferase
- gamma-Glutamyltransferase/blood